Management of Antipsychotic Medication Side Effects

Introduction to Antipsychotic Medications

Antipsychotic medications, such as risperidone, are associated with common side effects, including somnolence, headache, weight gain, and increased appetite, which clinicians should be aware of, particularly in children and elderly patients 1
Atypical antipsychotics have a distinct pharmacological profile, with a higher affinity for serotonin 5-HT2A receptors compared to dopamine D2 receptors, contributing to their improved side effect profile 2
Atypical antipsychotics demonstrate serotonergic actions, contributing to efficacy against both positive and negative symptoms, with potential cognitive benefits through 5-HT1A stimulation and 5-HT6/5-HT7 antagonism, as supported by the American Academy of Child and Adolescent Psychiatry 2

The risk of Extrapyramidal Symptoms (EPS) varies among antipsychotics, with risperidone having a moderate risk, olanzapine having a low risk, and typical antipsychotics having a high risk 2
Weight gain is a significant side effect of antipsychotics, with moderate to significant increases in weight, especially in children, and an increased risk of hyperglycemia and diabetes 1
Hyperprolactinemia is a significant side effect of risperidone, with a higher risk than other atypical antipsychotics, and clinicians should be aware of the potential for gynecomastia, galactorrhea, and menstrual irregularities 1
Orthostatic hypotension is a significant side effect of risperidone, especially in elderly patients, with a risk of QT prolongation and rare cases of sinus arrest causing syncope 2

Antipsychotic	EPS Risk	Weight Gain	Sedation	Metabolic Effects	Prolactin	Unique Concerns
Olanzapine	Low	High	High	High	Low	Significant anticholinergic effects
Risperidone	Moderate	Moderate	Low	Moderate	High	QT prolongation, orthostatic hypotension
Clozapine	Very low	High	High	High	Low	Agranulocytosis (1%), seizures (3%), requires monitoring
Haloperidol	High	Low	Low	Low	High	High EPS, tardive dyskinesia risk

The American Academy of Child and Adolescent Psychiatry recommends careful monitoring of patients taking antipsychotics due to the risk of EPS, hyperprolactinemia, and metabolic disturbances 1
Regular weight monitoring, periodic assessment of metabolic parameters, and observation for emergence of EPS are crucial for minimizing the risks associated with antipsychotics 1
Children with intellectual disability may require lower doses of antipsychotics due to increased sensitivity to side effects 1
The American Academy of Child and Adolescent Psychiatry recommends conservative dosing of antipsychotics to minimize side effects, with initial doses of 0.25 mg/day for irritability in autism and maximum doses of 2-3 mg/day 3

Risperidone is indicated for the treatment of schizophrenia in adults and adolescents (13-17 years), bipolar I disorder in children and adolescents (10-17 years), and irritability associated with autistic disorder in children and adolescents (5-16 years) 2
For first-episode schizophrenia, consider atypical antipsychotics first due to lower EPS risk, for treatment-resistant cases clozapine remains the gold standard despite monitoring requirements, and for bipolar disorder olanzapine, risperidone, and other atypicals are effective for acute mania and maintenance 2
Common pitfalls in antipsychotic management include underestimating metabolic risks, misinterpreting akathisia, using excessive doses, failing to recognize higher sensitivity to side effects in children and adolescents, and overlooking drug interactions 2
The American Academy of Child and Adolescent Psychiatry guidelines support that when side effects occur with an antipsychotic medication, switching to another medication with a different side effect profile is an appropriate strategy 2